Virus-like particles induce robust human T-helper cell responses

被引:67
|
作者
Braun, Marion [1 ]
Jandus, Camilla [2 ]
Maurer, Patrik [3 ]
Hammann-Haenni, Anya [3 ]
Schwarz, Katrin [3 ]
Bachmann, Martin F. [3 ]
Speiser, Daniel E. [1 ]
Romero, Pedro [1 ]
机构
[1] Univ Lausanne, Ludwig Ctr Canc Res, CH-1011 Lausanne, Switzerland
[2] Univ Bern, Inst Pharmacol, Bern, Switzerland
[3] Cytos Biotechnol, Schlieren, Switzerland
基金
瑞士国家科学基金会;
关键词
Cancer immunotherapy; Immunomonitoring; Melanoma; Th1; Virus-like particles; IMMUNE-RESPONSE; ANTIGEN; MEMORY; LYMPHOCYTES; GENERATION; CD8; VACCINATION; SUBCLASSES; PROTEIN; SAFE;
D O I
10.1002/eji.201142064
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Among synthetic vaccines, virus-like particles (VLPs) are used for their ability to induce strong humoral responses. Very little is reported on VLP-based-vaccine-induced CD4+ T-cell responses, despite the requirement of helper T cells for antibody isotype switching. Further knowledge on helper T cells is also needed for optimization of CD8+ T-cell vaccination. Here, we analysed human CD4+ T-cell responses to vaccination with MelQbG10, which is a Q beta-VLP covalently linked to a long peptide derived from the melanoma self-antigen Melan-A. In all analysed patients, we found strong antibody responses of mainly IgG1 and IgG3 isotypes, and concomitant Th1-biased CD4+ T-cell responses specific for Q beta. Although less strong, comparable B- and CD4+ T-cell responses were also found specific for the Melan-A cargo peptide. Further optimization is required to shift the response more towards the cargo peptide. Nevertheless, the data demonstrate the high potential of VLPs for inducing humoral and cellular immune responses by mounting powerful CD4+ T-cell help.
引用
收藏
页码:330 / 340
页数:11
相关论文
共 50 条
  • [31] VIRUS-LIKE PARTICLES IN HUMAN CHLOROLEUKEMIA CELLS
    OTA, Z
    SUZUKI, S
    HIGASHI, S
    GANN, 1963, 54 (04): : 481 - &
  • [32] VIRUS-LIKE PARTICLES IN HUMAN LEUKEMIC PLASMA
    BURGER, CL
    ANDERSON, NG
    HARRIS, WW
    KNISELEY, RM
    BARTLETT, TW
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1964, 115 (01): : 151 - &
  • [33] VIRUS-LIKE PARTICLES IN CULTURED HUMAN GLIOMA
    TANI, E
    TAKEUCHI, J
    AMETANI, T
    ACTA NEUROPATHOLOGICA, 1970, 16 (03) : 266 - +
  • [34] VIRUS-LIKE PARTICLES IN A HUMAN PRIMARY HEPATOCARCINOMA
    MA, MH
    BLACKBUR.CR
    NATURE, 1966, 212 (5064) : 854 - &
  • [35] Limited breadth of a T-helper cell response to a human immunodeficiency virus envelope protein
    Zhan, X
    Slobod, KS
    Surman, S
    Brown, SA
    Lockey, TD
    Coleclough, C
    Doherty, PC
    Hurwitz, JL
    JOURNAL OF VIROLOGY, 2003, 77 (07) : 4231 - 4236
  • [36] From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited
    Boniface, Katia
    Blom, Bianca
    Liu, Yong-Jun
    Malefyt, Rene de Waal
    IMMUNOLOGICAL REVIEWS, 2008, 226 : 132 - 146
  • [37] T-HELPER CELL CYTOTOXICITY
    PENNA, A
    GLASEBROOK, A
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 385 - 385
  • [38] Mosquito Cell-Derived Japanese Encephalitis Virus-Like Particles Induce Specific Humoral and Cellular Immune Responses in Mice
    Chang, Yu-Hsiu
    Chiao, Der-Jiang
    Hsu, Yu-Lin
    Lin, Chang-Chi
    Wu, Hsueh-Ling
    Shu, Pei-Yun
    Chang, Shu-Fen
    Chang, Jui-Huan
    Kuo, Szu-Cheng
    VIRUSES-BASEL, 2020, 12 (03):
  • [39] A virus-like particle of the hepatitis B virus preS antigen elicits robust neutralizing antibodies and T cell responses in mice
    Cai, Xiaodan
    Zheng, Weihao
    Pan, Shaokun
    Zhang, Shengyuan
    Xie, Youhua
    Guo, Haitao
    Wang, Guoxin
    Li, Zigang
    Luo, Ming
    ANTIVIRAL RESEARCH, 2018, 149 : 48 - 57
  • [40] IDENTIFICATION OF MENGO-VIRUS T-HELPER CELL EPITOPES
    MUIR, S
    KOBASA, D
    BITTLE, J
    SCRABA, D
    JOURNAL OF GENERAL VIROLOGY, 1994, 75 : 2925 - 2936